Lv11
80 积分 2026-01-08 加入
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease
5小时前
已完结
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II
1个月前
已完结
Evolution and trajectory of B-cell targeted therapies in rheumatic diseases
1个月前
已完结
Tarlatamab: First Approval
2个月前
已完结
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas
2个月前
已完结
皖公网安备34019202002308
